The rising prevalence of cardiovascular diseases has been a key factor driving the growth of the angiography devices market. The prevalence of the disease is likely to grow at a rate of 2.3% in the forecast period of 2024-2032. The wide-ranging scope of application and technological innovation are anticipated to be the primary growth drivers for the market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
In August 2023, Royal Philips, a global healthcare company, announced the application of intravascular ultrasounds for diagnosing and treating vascular disease. This will help in the precise and timely diagnosis of cardiovascular disorders.
In July 2023, Cleerly paved the way for bringing its non-invasive artificial intelligence software into the market so that more people can avail these devices. This device will help in the diagnosis of plaque present in the arteries.
In July 2023, Synchron announced the completion of the first human implant of a brain-computer interface. This was achieved with the help of non-invasive diagnostic procedures and has a vast treatment potential.
Angiography is a medical imaging technique that assists in the diagnosis and treatment of several disorders. This method generally views the body’s inside organs, with specific emphasis on arteries and veins.
Angiography is done with the incorporation of angiography devices. These devices hold a significant role in therapeutic and diagnostic purposes. The cardiovascular and hepatobiliary are among the two major areas incorporated by angiography devices. The utilisation of fluoroscopic impulses in this technique has been seeking the attention of healthcare technicians.
Angiographic devices need to be inserted into the body, and through fluoroscopic technique, imaging is done to visualise the inner structure. An angiography system consists of a patient bed, an X-ray tube, and a detector.
In this process, a thin tube, a catheter, is used to inject the contrast agents into the bloodstream, which helps detect any blockages through the arteries, veins, or other blood vessels in the circulatory system. These contrast agents are referred to as angiograms.
The other functions of angiography devices are to diagnose kidney cysts, cardiovascular disorders, aneurysms, tumours, ocular problems, and abnormal tangles in the brain. This technique also provides a precise image of the heart before open heart surgery and an accurate picture of the brain before neurosurgery.
According to the angiography devices market research report, the market can be categorised into the following segments:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product
Market Breakup by Indication
Market Breakup by Application
Market Breakup by Distribution Channels
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing prevalence of cardiovascular disorders demands more angiography devices. These devices help in the diagnosis and treatment of cardiac diseases. This will help grow the angiography devices market at a significant rate.
The advancements in the devices and technologies increase the efficiency and preciseness of angiography devices. Thus, this factor is also expected to stimulate the angiography devices’ market size.
Due to the need for advanced devices, there is an increased expenditure in the research and development sector in developing and developed nations. In addition, more significant investments by the top companies have also propelled the expansion of the angiography devices market.
There is also a significant upsurge in the funding by the government in the healthcare sector. This will help in the advancements in the healthcare industry, which will drive the growth of this market. Along with that, the increasing adoption of innovative technology will assist in the development of the angiography devices market.
The increasing number of collaborations and acquisitions among the key companies developing angiography devices is anticipated to provide lucrative opportunities in this device market. However, the high costs associated with the research and development and limited framework are expected to affect the growth of the angiography devices market.
North America accounts for the largest share of the global angiography devices market owing to the rising geriatric population and unhealthy lifestyle habits in that region. Apart from that, the rising per capita expenditure and minimally invasive methods are also responsible for the dominance of the region.
Angiography is a technique incorporated to get a detailed structural and anatomical image of the circulatory system to diagnose and detect damaged vessels or blood clots. The application of angiography devices was earlier limited to diagnostic purposes, but with technological advancements, this has expanded to the field of interventional therapies.
The invasive and non-invasive angiography strategies have been a cornerstone for diagnostic and therapeutic purposes in intravascular organs. The application of X-rays and Computed Tomography scans (CT) help in the early diagnosis of any pathological disease or disorder.
The application of devices in the cardiovascular sector accounts for the largest share of the angiography devices market. Angiography helps in the diagnosis of aortic aneurysms and dissection. This helps in the treatment of coronary artery disease and vascular malformations.
Angiography devices are also utilised in the neuromuscular sector. This helps in the diagnosis of intracranial and extracranial disease indications.
Angiography devices have a wide prevalence in diagnosing pulmonary and respiratory haemorrhages. The X-rays are primarily used to identify any obstructions or blockages in the windpipe and lungs.
Gastrointestinal or renal disorders can also be diagnosed with the help of angiography devices. The early diagnosis of acute mesenteric ischemia helps in the timely restoration of blood flow. These devices assist in the prior mapping of the fistula before the dialysis.
The angiographic devices mainly help in the process of embolisation, a method to stop or block the blood flow to abnormal or tumour-affected regions of the body. Catheter embolisation is one technique that incorporates the embolic agents into a blood vessel to stop the abnormal blood flow. This will also help to rectify the abnormal connections between arteries and veins.
The angiography devices are of great use for interventional radiologists. These devices help in incorporating chemotherapies. The different types of tumours, be they benign or malignant, can also be identified with the help of angiography.
The plaques formed in the carotid artery can also be diagnosed with the help of angiography devices. If not treated at the early stages, these plaques can rupture and cause the complete stoppage of blood flow and thus can lead to untimely death.
With the high treatment potential, the angiography devices market possesses an excellent opportunity for healthcare industries and pharmaceutical companies in extensive therapeutic and diagnostic methods.
With the advent of new technologies, many innovative technological devices have come into the picture. Earlier, angiography devices had limited diagnostic uses, but now, these devices possess a wide range of applications. The researchers developed novel therapeutic applications, which will help expand the angiography devices market.
Incorporating invasive and non-invasive strategies for angiography is also under extensive testing. These strategies will help in the precise diagnosis of the disease and will save time and costs.
A new cardiac technology using multislice computed tomography is under evaluation. This novel slice technology is anticipated to provide fast and safe CT scans.
The new systems, recently approved by USFDA, combined the two different approaches into one, which helps in providing more efficient results. In these systems, Computed Tomography (CT) is combined with Magnetic Resonance Imaging (MRI) for better visualisation of anatomical structures.
Another modern application, discovered by Siemens, integrates angiography and ultrasound to produce detailed images of the vascular system. This will further help in cardiac mapping and procedures.
Intravascular Lithotripsy is a new technology that produces pressure waves to break the plaques and help restore normal blood flow. These pressure waves are produced by a generator which is directed to the targeted site. This technology is under clinical trials and is anticipated to provide a brighter outlook once approved.
Artificial intelligence is also expected to play a vital role in the processing of angiography devices. This will provide lucrative opportunities in the healthcare sector. Artificial intelligence has reduced the processing time of cardiac MRI and produces a detailed view of echocardiograms.
These novel targeted devices and technologies seem to grab the attention of key companies and investors, which will directly influence the development in this sector. This will help enable patient access and growth of the angiography devices market.
The report gives an in-depth analysis of the key players involved in the angiography devices market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
|Scope of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product
|Breakup by Indication
|Breakup by Application
|Breakup by Distribution Channels
|Breakup by Region
|Trade Data Analysis
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.1.1 Research Objectives
1.1.2 Key Findings of the Report
1.2 Limitations of the Study and Scope for Future Research
2 Research Methodology
3 Executive Summary
4 Global Angiography Devices Market
4.1 Global Angiography Devices Market Overview
4.2 Global Angiography Devices Market Analysis
4.2.1 Market Overview
126.96.36.199 Global Angiography Devices Market Historical Value (2017-2023)
188.8.131.52 Global Angiography Devices Market Forecast Value (2024-2032)
4.3 Global Angiography Devices Market by Product
4.3.1 Market Overview
184.108.40.206 Angiography Systems
220.127.116.11 Contrast Media
18.104.22.168 Vascular Closure Devices
22.214.171.124 Angiography Accessories
4.4 Global Angiography Devices Market by Indication
4.4.1 Market Overview
4.5 Global Angiography Devices Market by Application
4.5.1 Market Overview
126.96.36.199.2 Computed Tomography (CT)
188.8.131.52.3 Magnetic Resonance Angiography (MRA)
184.108.40.206.1 Coronary Angiography
220.127.116.11.2 Micro Angiography
18.104.22.168.3 Non-Coronary Angiography
22.214.171.124.3.1 Neurovascular Angiography
126.96.36.199.3.2 Peripheral Angiography
4.6 Global Angiography Devices Market by Distribution Channels
4.6.1 Market Overview
188.8.131.52 Diagnostic Centers
184.108.40.206 Research Laboratories
4.7 Global Angiography Devices Market by Region
4.7.1 Market Overview
220.127.116.11 North America
18.104.22.168 Asia Pacific
22.214.171.124 Latin America
126.96.36.199 Middle East and Africa
4.7.2 North America
188.8.131.52 Historical Trend (2017-2023)
184.108.40.206 Forecast Trend (2024-2032)
220.127.116.11 Break Up by Country
18.104.22.168.1 United States of America
22.214.171.124 Historical Trend (2017-2023)
126.96.36.199 Forecast Trend (2024-2032)
188.8.131.52 Break Up by Country
184.108.40.206.1 United Kingdom
4.7.4 Asia Pacific
220.127.116.11 Historical Trend (2017-2023)
18.104.22.168 Forecast Trend (2024-2032)
22.214.171.124 Break Up by Country
4.7.5 Latin America
126.96.36.199 Historical Trend (2017-2023)
188.8.131.52 Forecast Trend (2024-2032)
184.108.40.206 Break Up by Country
4.7.6 Middle East and Africa
220.127.116.11 Historical Trend (2017-2023)
18.104.22.168 Forecast Trend (2024-2032)
22.214.171.124 Break Up by Country
126.96.36.199.1 Saudi Arabia
188.8.131.52.2 United Arab Emirates
184.108.40.206.4 South Africa
5 Trade Data Analysis by HS Code
5.1 Angiography Diagnostic System- 90189019
5.2 Cardiac and Vascular Angiography System - 90189099
6 Current Scenario Evaluation and Regulatory Framework
6.1 Emerging Therapies and Clinical Trials Synopsis
6.2 Patent Landscape
6.2.1 Patent Overview
220.127.116.11 Patent Status and Expiry
18.104.22.168 Timelines from Device Development to Commercial Launch
22.214.171.124 New Device Application
126.96.36.199.1 Documentation and Approval Process
6.3 Cost of Treatment
6.4 Regulatory Framework
6.4.1 Regulatory Overview
188.8.131.52 US FDA
184.108.40.206 EU EMA
220.127.116.11 INDIA CDSCO
18.104.22.168 JAPAN PMDA
7 Global Angiography Devices Market Dynamics
7.1 Market Drivers and Constraints
7.2 SWOT Analysis
7.3 Porter’s Five Forces Model
7.4 Key Demand Indicators
7.5 Key Price Indicators
7.6 Industry Events, Initiatives, and Trends
7.7 Value Chain Analysis
8 Supplier Landscape
8.1 Siemens AG
8.1.1 Company Overview
8.1.2 Product Portfolio
8.1.3 Demographic Reach and Achievements
8.1.4 Mergers and Acquisitions
8.2 Canon Medical Systems Corporation
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Demographic Reach and Achievements
8.2.4 Mergers and Acquisitions
8.3 Medtronic plc
8.3.1 Company Overview
8.3.2 Product Portfolio
8.3.3 Demographic Reach and Achievements
8.3.4 Mergers and Acquisitions
8.4 Koninklijke Philips N.V.
8.4.1 Company Overview
8.4.2 Product Portfolio
8.4.3 Demographic Reach and Achievements
8.4.4 Mergers and Acquisitions
8.5 Boston Scientific Corporation
8.5.1 Company Overview
8.5.2 Product Portfolio
8.5.3 Demographic Reach and Achievements
8.5.4 Mergers and Acquisitions
8.6 Johnson & Johnson
8.6.1 Company Overview
8.6.2 Product Portfolio
8.6.3 Demographic Reach and Achievements
8.6.4 Mergers and Acquisitions
8.7 Abbott Laboratories
8.7.1 Company Overview
8.7.2 Product Portfolio
8.7.3 Demographic Reach and Achievements
8.7.4 Mergers and Acquisitions
8.8 Cook Group Incorporated
8.8.1 Company Overview
8.8.2 Product Portfolio
8.8.3 Demographic Reach and Achievements
8.8.4 Mergers and Acquisitions
8.9 General Electric Company
8.9.1 Company Overview
8.9.2 Product Portfolio
8.9.3 Demographic Reach and Achievements
8.9.4 Mergers and Acquisitions
8.10 Shimadzu Corporation
8.10.1 Company Overview
8.10.2 Product Portfolio
8.10.3 Demographic Reach and Achievements
8.10.4 Mergers and Acquisitions
8.11 St. Jude Medical
8.11.1 Company Overview
8.11.2 Product Portfolio
8.11.3 Demographic Reach and Achievements
8.11.4 Mergers and Acquisitions
8.12 B. Braun Melsungen AG
8.12.1 Company Overview
8.12.2 Product Portfolio
8.12.3 Demographic Reach and Achievements
8.12.4 Mergers and Acquisitions
8.13 GE Healthcare
8.13.1 Company Overview
8.13.2 Product Portfolio
8.13.3 Demographic Reach and Achievements
8.13.4 Mergers and Acquisitions
8.14 Cardinal Health, Inc.
8.14.1 Company Overview
8.14.2 Product Portfolio
8.14.3 Demographic Reach and Achievements
8.14.4 Mergers and Acquisitions
9 Recommendations and Discussion
10 Pricing Models and Strategies (Additional Insight)
10.2 Cost Model
10.2.1 Manufacturing Cost Analysis
10.2.2 Procurement Cost Analysis
10.2.3 Clinical Trial Cost Factors
10.3 Pricing Strategies
10.3.1 Competitor Pricing Analysis
10.3.2 Key Assessment of Product Attributes
10.3.3 Pricing Benchmark
11 Global Angiography Devices Distribution Model (Additional Insight)
11.2 Potential Distributors
11.3 Key Parameters for Distribution Partner Assessment
*Additional insights provided are customisable as per client requirements.
The rising cardiovascular cases, technological advancements, and increased expenditure in the research and developmental sector are the key factors responsible for driving this market growth.
Based on the product, the market is segmented into angiography systems, balloons, catheters, contrast media, guidewire, vascular closure devices, and angiography accessories, among others.
Based on the application, the market is divided into the diagnostics and therapeutics sectors, among others.
Cardiovascular segment accounts for the highest share in this market.
The different regions are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America accounts for the highest share of this market.
The distribution channels in this market are hospitals, research laboratories, and diagnostic centres.
Based on indication, the market can be divided into cerebral, carotid, peripheral, aortic, and coronary, among others.
Angiography is a medical imaging technique assisting in the diagnosis and treatment of several disorders.
The equipment used in the angiography include radiographic table, X-ray tubes, and visual monitors.
The key players in this market are Siemens AG, Canon Medical Systems Corporation, Medtronic plc, Koninklijke Philips N.V., Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, Cook Group Incorporated, General Electric Company, Shimadzu Corporation, St. Jude Medical, B. Braun Melsungen AG, GE Healthcare, and Cardinal Health, Inc., among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.